Form 8-K - Current report:
SEC Accession No. 0001193125-24-090917
Filing Date
2024-04-09
Accepted
2024-04-09 16:49:49
Documents
3
Period of Report
2024-04-09
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d811673d8k.htm 8-K 22372
2 EX-3.1 d811673dex31.htm EX-3.1 41252
3 EX-3.2 d811673dex32.htm EX-3.2 165934
  Complete submission text file 0001193125-24-090917.txt   230871
Mailing Address 10578 SCIENCE CENTER DRIVE, SUITE 200 SAN DIEGO CA 92121
Business Address 10578 SCIENCE CENTER DRIVE, SUITE 200 SAN DIEGO CA 92121 (858) 333-5280
Contineum Therapeutics, Inc. (Filer) CIK: 0001855175 (see all company filings)

EIN.: 271467257 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-42001 | Film No.: 24833291
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)